Literature DB >> 7571423

Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.

S Nakagawa1, S Watanabe, H Yoshikawa, Y Taketani, K Yoshiike, T Kanda.   

Abstract

The E6 oncoprotein of human papillomavirus type 16 (HPV 16) [151amino acids (AA) long] contains four metal-binding motifs, C-X-X-C, and is postulated to form two 29-AA finger-like structures in the N-terminal and C-terminal halves, which mediate degradation of p53 and binding to p53, respectively. We constructed a series of E6 mutants with single-AA substitutions in these finger regions (AAs 34-62 and 107-135) and examined their transforming function for human embryonic kidney (HEK) cells in conjunction with HPV 16 E7 and their interaction with human p53 in vitro. The mutants with substitution of L for F-37, G for L-50, S for Y-54, and P for L-110, which did not transform HEK cells, showed markedly lowered activity to direct degradation of p53. The mutants with substitutions of G for R-39, G for V-42, G for Y-43, L for F-47, and G for V-53 lost the transforming function, but they could mediate degradation of p53 at levels comparable to the activities of the wild-type and transforming mutants. Like the wild type, all of the E6 mutants were localized by immunofluorescence to the nuclei of human TS21B cells or monkey COS-1 cells, except for the E6 mutant with substitution of G for Y-43 whose expression was undetectable. The levels of E6 mutants metabolically labeled in COS-1 cells were comparable to those of the transforming E6s. The data indicate that E6-directed degradation of p53 is necessary but not sufficient for HPV 16-mediated transformation of of HEK cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7571423     DOI: 10.1006/viro.1995.1511

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Transforming activity of a novel mutant of HPV16 E6E7 fusion gene.

Authors:  Qiang Xie; Zhi-Xiang Zhou; Ze-Lin Li; Yi Zeng
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

3.  Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.

Authors:  S Song; G A Gulliver; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.

Authors:  Yves Nominé; Sebastian Charbonnier; Laurent Miguet; Noelle Potier; Alain Van Dorsselaer; R Andrew Atkinson; Gilles Travé; Bruno Kieffer
Journal:  J Biomol NMR       Date:  2005-02       Impact factor: 2.835

5.  Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.

Authors:  Yuji Masuda; Yasushi Saeki; Naoko Arai; Hidehiko Kawai; Iwao Kukimoto; Keiji Tanaka; Chikahide Masutani
Journal:  J Biol Chem       Date:  2019-09-06       Impact factor: 5.157

6.  Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.

Authors:  Y Liu; J J Chen; Q Gao; S Dalal; Y Hong; C P Mansur; V Band; E J Androphy
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.

Authors:  H Zimmermann; R Degenkolbe; H U Bernard; M J O'Connor
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Gps2, a protein partner for human papillomavirus E6 proteins.

Authors:  Y Y Degenhardt; S J Silverstein
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways.

Authors:  Lucia G Le Roux; Junona Moroianu
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice.

Authors:  D Mendoza-Villanueva; J Diaz-Chavez; L Uribe-Figueroa; C Rangel-Escareão; A Hidalgo-Miranda; S March-Mifsut; G Jimenez-Sanchez; Pf Lambert; P Gariglio
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.